7-methyl-9-[[4-[1-(1-methylazetidin-3-yl)-4-(trifluoromethyl)imidazol-2-yl]phenyl]methyl]-2-(2-propan-2-ylphenyl)purin-8-one;7-methyl-9-[[1-(1-methylimidazol-2-yl)sulfonylpiperidin-4-yl]methyl]-2-(2-propan-2-ylphenyl)purin-8-one;7-methyl-2-(2-propan-2-ylphenyl)-9-[(1-propan-2-ylsulfonylpiperidin-4-yl)methyl]purin-8-one;7-methyl-2-(2-propan-2-ylphenyl)-9-[(1-pyridin-3-ylsulfonylpiperidin-4-yl)methyl]purin-8-one

C105H124F3N25O10S3 — CID 158626176

IUPAC7-methyl-9-[[4-[1-(1-methylazetidin-3-yl)-4-(trifluoromethyl)imidazol-2-yl]phenyl]methyl]-2-(2-propan-2-ylphenyl)purin-8-one;7-methyl-9-[[1-(1-methylimidazol-2-yl)sulfonylpiperidin-4-yl]methyl]-2-(2-propan-2-ylphenyl)purin-8-one;7-methyl-2-(2-propan-2-ylphenyl)-9-[(1-propan-2-ylsulfonylpiperidin-4-yl)methyl]purin-8-one;7-methyl-2-(2-propan-2-ylphenyl)-9-[(1-pyridin-3-ylsulfonylpiperidin-4-yl)methyl]purin-8-one
SMILESCC(C)c1ccccc1-c1ncc2c(n1)n(CC1CCN(S(=O)(=O)C(C)C)CC1)c(=O)n2C.CC(C)c1ccccc1-c1ncc2c(n1)n(CC1CCN(S(=O)(=O)c3cccnc3)CC1)c(=O)n2C.CC(C)c1ccccc1-c1ncc2c(n1)n(CC1CCN(S(=O)(=O)c3nccn3C)CC1)c(=O)n2C.CC(C)c1ccccc1-c1ncc2c(n1)n(Cc1ccc(-c3nc(C(F)(F)F)cn3C3CN(C)C3)cc1)c(=O)n2C
InChIInChI=1S/C30H30F3N7O.C26H30N6O3S.C25H31N7O3S.C24H33N5O3S/c1-18(2)22-7-5-6-8-23(22)26-34-13-24-28(36-26)40(29(41)38(24)4)14-19-9-11-20(12-10-19)27-35-25(30(31,32)33)17-39(27)21-15-37(3)16-21;1-18(2)21-8-4-5-9-22(21)24-28-16-23-25(29-24)32(26(33)30(23)3)17-19-10-13-31(14-11-19)36(34,35)20-7-6-12-27-15-20;1-17(2)19-7-5-6-8-20(19)22-27-15-21-23(28-22)32(25(33)30(21)4)16-18-9-12-31(13-10-18)36(34,35)24-26-11-14-29(24)3;1-16(2)19-8-6-7-9-20(19)22-25-14-21-23(26-22)29(24(30)27(21)5)15-18-10-12-28(13-11-18)33(31,32)17(3)4/h5-13,17-18,21H,14-16H2,1-4H3;4-9,12,15-16,18-19H,10-11,13-14,17H2,1-3H3;5-8,11,14-15,17-18H,9-10,12-13,16H2,1-4H3;6-9,14,16-18H,10-13,15H2,1-5H3
InChIKeyHYPRHZVTQKOMRL-UHFFFAOYSA-N
MW2049.51 g/mol
LogP14.88
Rot. Bonds24

About 7-methyl-9-[[4-[1-(1-methylazetidin-3-yl)-4-(trifluoromethyl)imidazol-2-yl]phenyl]methyl]-2-(2-propan-2-ylphenyl)purin-8-one;7-methyl-9-[[1-(1-methylimidazol-2-yl)sulfonylpiperidin-4-yl]methyl]-2-(2-propan-2-ylphenyl)purin-8-one;7-methyl-2-(2-propan-2-ylphenyl)-9-[(1-propan-2-ylsulfonylpiperidin-4-yl)methyl]purin-8-one;7-methyl-2-(2-propan-2-ylphenyl)-9-[(1-pyridin-3-ylsulfonylpiperidin-4-yl)methyl]purin-8-one

7-methyl-9-[[4-[1-(1-methylazetidin-3-yl)-4-(trifluoromethyl)imidazol-2-yl]phenyl]methyl]-2-(2-propan-2-ylphenyl)purin-8-one;7-methyl-9-[[1-(1-methylimidazol-2-yl)sulfonylpiperidin-4-yl]methyl]-2-(2-propan-2-ylphenyl)purin-8-one;7-methyl-2-(2-propan-2-ylphenyl)-9-[(1-propan-2-ylsulfonylpiperidin-4-yl)methyl]purin-8-one;7-methyl-2-(2-propan-2-ylphenyl)-9-[(1-pyridin-3-ylsulfonylpiperidin-4-yl)methyl]purin-8-one (PubChem CID 158626176) has the molecular formula C105H124F3N25O10S3 and a molecular weight of 2049.51 g/mol. Its IUPAC name is 7-methyl-9-[[4-[1-(1-methylazetidin-3-yl)-4-(trifluoromethyl)imidazol-2-yl]phenyl]methyl]-2-(2-propan-2-ylphenyl)purin-8-one;7-methyl-9-[[1-(1-methylimidazol-2-yl)sulfonylpiperidin-4-yl]methyl]-2-(2-propan-2-ylphenyl)purin-8-one;7-methyl-2-(2-propan-2-ylphenyl)-9-[(1-propan-2-ylsulfonylpiperidin-4-yl)methyl]purin-8-one;7-methyl-2-(2-propan-2-ylphenyl)-9-[(1-pyridin-3-ylsulfonylpiperidin-4-yl)methyl]purin-8-one.

Molecular Properties

Compound Name7-methyl-9-[[4-[1-(1-methylazetidin-3-yl)-4-(trifluoromethyl)imidazol-2-yl]phenyl]methyl]-2-(2-propan-2-ylphenyl)purin-8-one;7-methyl-9-[[1-(1-methylimidazol-2-yl)sulfonylpiperidin-4-yl]methyl]-2-(2-propan-2-ylphenyl)purin-8-one;7-methyl-2-(2-propan-2-ylphenyl)-9-[(1-propan-2-ylsulfonylpiperidin-4-yl)methyl]purin-8-one;7-methyl-2-(2-propan-2-ylphenyl)-9-[(1-pyridin-3-ylsulfonylpiperidin-4-yl)methyl]purin-8-one
PubChem CID158626176
Molecular FormulaC105H124F3N25O10S3
Molecular Weight2049.51 g/mol
Exact Mass2047.91
IUPAC Name7-methyl-9-[[4-[1-(1-methylazetidin-3-yl)-4-(trifluoromethyl)imidazol-2-yl]phenyl]methyl]-2-(2-propan-2-ylphenyl)purin-8-one;7-methyl-9-[[1-(1-methylimidazol-2-yl)sulfonylpiperidin-4-yl]methyl]-2-(2-propan-2-ylphenyl)purin-8-one;7-methyl-2-(2-propan-2-ylphenyl)-9-[(1-propan-2-ylsulfonylpiperidin-4-yl)methyl]purin-8-one;7-methyl-2-(2-propan-2-ylphenyl)-9-[(1-pyridin-3-ylsulfonylpiperidin-4-yl)methyl]purin-8-one
SMILESCC(C)c1ccccc1-c1ncc2c(n1)n(CC1CCN(S(=O)(=O)C(C)C)CC1)c(=O)n2C.CC(C)c1ccccc1-c1ncc2c(n1)n(CC1CCN(S(=O)(=O)c3cccnc3)CC1)c(=O)n2C.CC(C)c1ccccc1-c1ncc2c(n1)n(CC1CCN(S(=O)(=O)c3nccn3C)CC1)c(=O)n2C.CC(C)c1ccccc1-c1ncc2c(n1)n(Cc1ccc(-c3nc(C(F)(F)F)cn3C3CN(C)C3)cc1)c(=O)n2C
InChIInChI=1S/C30H30F3N7O.C26H30N6O3S.C25H31N7O3S.C24H33N5O3S/c1-18(2)22-7-5-6-8-23(22)26-34-13-24-28(36-26)40(29(41)38(24)4)14-19-9-11-20(12-10-19)27-35-25(30(31,32)33)17-39(27)21-15-37(3)16-21;1-18(2)21-8-4-5-9-22(21)24-28-16-23-25(29-24)32(26(33)30(23)3)17-19-10-13-31(14-11-19)36(34,35)20-7-6-12-27-15-20;1-17(2)19-7-5-6-8-20(19)22-27-15-21-23(28-22)32(25(33)30(21)4)16-18-9-12-31(13-10-18)36(34,35)24-26-11-14-29(24)3;1-16(2)19-8-6-7-9-20(19)22-25-14-21-23(26-22)29(24(30)27(21)5)15-18-10-12-28(13-11-18)33(31,32)17(3)4/h5-13,17-18,21H,14-16H2,1-4H3;4-9,12,15-16,18-19H,10-11,13-14,17H2,1-3H3;5-8,11,14-15,17-18H,9-10,12-13,16H2,1-4H3;6-9,14,16-18H,10-13,15H2,1-5H3
InChIKeyHYPRHZVTQKOMRL-UHFFFAOYSA-N
XLogP14.88
TPSA374.75 Ų
H-Bond Donors
H-Bond Acceptors32
Rotatable Bonds24
Heavy Atoms146
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002049.51
LogP ≤ 514.88
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1032

Analyze 7-methyl-9-[[4-[1-(1-methylazetidin-3-yl)-4-(trifluoromethyl)imidazol-2-yl]phenyl]methyl]-2-(2-propan-2-ylphenyl)purin-8-one;7-methyl-9-[[1-(1-methylimidazol-2-yl)sulfonylpiperidin-4-yl]methyl]-2-(2-propan-2-ylphenyl)purin-8-one;7-methyl-2-(2-propan-2-ylphenyl)-9-[(1-propan-2-ylsulfonylpiperidin-4-yl)methyl]purin-8-one;7-methyl-2-(2-propan-2-ylphenyl)-9-[(1-pyridin-3-ylsulfonylpiperidin-4-yl)methyl]purin-8-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 7-methyl-9-[[4-[1-(1-methylazetidin-3-yl)-4-(trifluoromethyl)imidazol-2-yl]phenyl]methyl]-2-(2-propan-2-ylphenyl)purin-8-one;7-methyl-9-[[1-(1-methylimidazol-2-yl)sulfonylpiperidin-4-yl]methyl]-2-(2-propan-2-ylphenyl)purin-8-one;7-methyl-2-(2-propan-2-ylphenyl)-9-[(1-propan-2-ylsulfonylpiperidin-4-yl)methyl]purin-8-one;7-methyl-2-(2-propan-2-ylphenyl)-9-[(1-pyridin-3-ylsulfonylpiperidin-4-yl)methyl]purin-8-one?
The IUPAC name of 7-methyl-9-[[4-[1-(1-methylazetidin-3-yl)-4-(trifluoromethyl)imidazol-2-yl]phenyl]methyl]-2-(2-propan-2-ylphenyl)purin-8-one;7-methyl-9-[[1-(1-methylimidazol-2-yl)sulfonylpiperidin-4-yl]methyl]-2-(2-propan-2-ylphenyl)purin-8-one;7-methyl-2-(2-propan-2-ylphenyl)-9-[(1-propan-2-ylsulfonylpiperidin-4-yl)methyl]purin-8-one;7-methyl-2-(2-propan-2-ylphenyl)-9-[(1-pyridin-3-ylsulfonylpiperidin-4-yl)methyl]purin-8-one (CID 158626176) is 7-methyl-9-[[4-[1-(1-methylazetidin-3-yl)-4-(trifluoromethyl)imidazol-2-yl]phenyl]methyl]-2-(2-propan-2-ylphenyl)purin-8-one;7-methyl-9-[[1-(1-methylimidazol-2-yl)sulfonylpiperidin-4-yl]methyl]-2-(2-propan-2-ylphenyl)purin-8-one;7-methyl-2-(2-propan-2-ylphenyl)-9-[(1-propan-2-ylsulfonylpiperidin-4-yl)methyl]purin-8-one;7-methyl-2-(2-propan-2-ylphenyl)-9-[(1-pyridin-3-ylsulfonylpiperidin-4-yl)methyl]purin-8-one.
What is the SMILES notation for 7-methyl-9-[[4-[1-(1-methylazetidin-3-yl)-4-(trifluoromethyl)imidazol-2-yl]phenyl]methyl]-2-(2-propan-2-ylphenyl)purin-8-one;7-methyl-9-[[1-(1-methylimidazol-2-yl)sulfonylpiperidin-4-yl]methyl]-2-(2-propan-2-ylphenyl)purin-8-one;7-methyl-2-(2-propan-2-ylphenyl)-9-[(1-propan-2-ylsulfonylpiperidin-4-yl)methyl]purin-8-one;7-methyl-2-(2-propan-2-ylphenyl)-9-[(1-pyridin-3-ylsulfonylpiperidin-4-yl)methyl]purin-8-one?
The canonical SMILES for 7-methyl-9-[[4-[1-(1-methylazetidin-3-yl)-4-(trifluoromethyl)imidazol-2-yl]phenyl]methyl]-2-(2-propan-2-ylphenyl)purin-8-one;7-methyl-9-[[1-(1-methylimidazol-2-yl)sulfonylpiperidin-4-yl]methyl]-2-(2-propan-2-ylphenyl)purin-8-one;7-methyl-2-(2-propan-2-ylphenyl)-9-[(1-propan-2-ylsulfonylpiperidin-4-yl)methyl]purin-8-one;7-methyl-2-(2-propan-2-ylphenyl)-9-[(1-pyridin-3-ylsulfonylpiperidin-4-yl)methyl]purin-8-one is CC(C)c1ccccc1-c1ncc2c(n1)n(CC1CCN(S(=O)(=O)C(C)C)CC1)c(=O)n2C.CC(C)c1ccccc1-c1ncc2c(n1)n(CC1CCN(S(=O)(=O)c3cccnc3)CC1)c(=O)n2C.CC(C)c1ccccc1-c1ncc2c(n1)n(CC1CCN(S(=O)(=O)c3nccn3C)CC1)c(=O)n2C.CC(C)c1ccccc1-c1ncc2c(n1)n(Cc1ccc(-c3nc(C(F)(F)F)cn3C3CN(C)C3)cc1)c(=O)n2C.
What is the InChIKey of 7-methyl-9-[[4-[1-(1-methylazetidin-3-yl)-4-(trifluoromethyl)imidazol-2-yl]phenyl]methyl]-2-(2-propan-2-ylphenyl)purin-8-one;7-methyl-9-[[1-(1-methylimidazol-2-yl)sulfonylpiperidin-4-yl]methyl]-2-(2-propan-2-ylphenyl)purin-8-one;7-methyl-2-(2-propan-2-ylphenyl)-9-[(1-propan-2-ylsulfonylpiperidin-4-yl)methyl]purin-8-one;7-methyl-2-(2-propan-2-ylphenyl)-9-[(1-pyridin-3-ylsulfonylpiperidin-4-yl)methyl]purin-8-one?
The InChIKey is HYPRHZVTQKOMRL-UHFFFAOYSA-N. The full InChI is InChI=1S/C30H30F3N7O.C26H30N6O3S.C25H31N7O3S.C24H33N5O3S/c1-18(2)22-7-5-6-8-23(22)26-34-13-24-28(36-26)40(29(41)38(24)4)14-19-9-11-20(12-10-19)27-35-25(30(31,32)33)17-39(27)21-15-37(3)16-21;1-18(2)21-8-4-5-9-22(21)24-28-16-23-25(29-24)32(26(33)30(23)3)17-19-10-13-31(14-11-19)36(34,35)20-7-6-12-27-15-20;1-17(2)19-7-5-6-8-20(19)22-27-15-21-23(28-22)32(25(33)30(21)4)16-18-9-12-31(13-10-18)36(34,35)24-26-11-14-29(24)3;1-16(2)19-8-6-7-9-20(19)22-25-14-21-23(26-22)29(24(30)27(21)5)15-18-10-12-28(13-11-18)33(31,32)17(3)4/h5-13,17-18,21H,14-16H2,1-4H3;4-9,12,15-16,18-19H,10-11,13-14,17H2,1-3H3;5-8,11,14-15,17-18H,9-10,12-13,16H2,1-4H3;6-9,14,16-18H,10-13,15H2,1-5H3.
What are the key properties of 7-methyl-9-[[4-[1-(1-methylazetidin-3-yl)-4-(trifluoromethyl)imidazol-2-yl]phenyl]methyl]-2-(2-propan-2-ylphenyl)purin-8-one;7-methyl-9-[[1-(1-methylimidazol-2-yl)sulfonylpiperidin-4-yl]methyl]-2-(2-propan-2-ylphenyl)purin-8-one;7-methyl-2-(2-propan-2-ylphenyl)-9-[(1-propan-2-ylsulfonylpiperidin-4-yl)methyl]purin-8-one;7-methyl-2-(2-propan-2-ylphenyl)-9-[(1-pyridin-3-ylsulfonylpiperidin-4-yl)methyl]purin-8-one?
7-methyl-9-[[4-[1-(1-methylazetidin-3-yl)-4-(trifluoromethyl)imidazol-2-yl]phenyl]methyl]-2-(2-propan-2-ylphenyl)purin-8-one;7-methyl-9-[[1-(1-methylimidazol-2-yl)sulfonylpiperidin-4-yl]methyl]-2-(2-propan-2-ylphenyl)purin-8-one;7-methyl-2-(2-propan-2-ylphenyl)-9-[(1-propan-2-ylsulfonylpiperidin-4-yl)methyl]purin-8-one;7-methyl-2-(2-propan-2-ylphenyl)-9-[(1-pyridin-3-ylsulfonylpiperidin-4-yl)methyl]purin-8-one has a molecular weight of 2049.51 g/mol, XLogP of 14.88, 24 rotatable bonds, 0 hydrogen bond donors, and 32 hydrogen bond acceptors.
Where does this data come from?
All data for 7-methyl-9-[[4-[1-(1-methylazetidin-3-yl)-4-(trifluoromethyl)imidazol-2-yl]phenyl]methyl]-2-(2-propan-2-ylphenyl)purin-8-one;7-methyl-9-[[1-(1-methylimidazol-2-yl)sulfonylpiperidin-4-yl]methyl]-2-(2-propan-2-ylphenyl)purin-8-one;7-methyl-2-(2-propan-2-ylphenyl)-9-[(1-propan-2-ylsulfonylpiperidin-4-yl)methyl]purin-8-one;7-methyl-2-(2-propan-2-ylphenyl)-9-[(1-pyridin-3-ylsulfonylpiperidin-4-yl)methyl]purin-8-one is sourced from PubChem (CID 158626176), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).